OTCMKTS:NWBO Northwest Biotherapeutics (NWBO) Stock Price, News & Analysis $0.42 0.00 (0.00%) (As of 07/3/2024 ET) Add Compare Share Share Today's Range$0.40▼$0.4350-Day Range$0.41▼$0.5052-Week Range$0.40▼$1.09Volume1.10 million shsAverage Volume1.71 million shsMarket Capitalization$512.59 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Northwest Biotherapeutics alerts: Email Address Ad Digital Mavericks Media1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income every month.Click here to check it out. About Northwest Biotherapeutics Stock (OTCMKTS:NWBO)Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.Read More NWBO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NWBO Stock News HeadlinesJuly 3 at 11:56 AM | prnewswire.comNorthwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews Strong Progress and Growth OpportunitiesJuly 2 at 8:46 AM | americanbankingnews.comNorthwest Biotherapeutics, Inc. (OTCMKTS:NWBO) Sees Large Decrease in Short InterestJuly 4, 2024 | Digital Mavericks Media (Ad)1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income every month.June 27, 2024 | americanbankingnews.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Shares Pass Below 200 Day Moving Average of $0.55June 17, 2024 | prnewswire.comNorthwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual PropertyMay 25, 2024 | nasdaq.comNorthwest Biotherapeutics Inc (NWBO) Dividend HistoryMarch 21, 2024 | prnewswire.comNorthwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of DirectorsMarch 2, 2024 | ft.com‘Spoofing’ case might draw back curtain on high-speed trading firmsJuly 4, 2024 | Digital Mavericks Media (Ad)1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income every month.February 29, 2024 | uk.finance.yahoo.comNorthwest Biotherapeutics, Inc. (NWBO)February 23, 2024 | benzinga.comNorthwest Biotherapeutics Stock (OTC:NWBO), Short Interest ReportFebruary 7, 2024 | finance.yahoo.comNorthwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory CertificationDecember 22, 2023 | msn.comNorthwest Biotherapeutics submits marketing application to UK MHRA for DCVax-LDecember 21, 2023 | finanznachrichten.deNorthwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax-L For GlioblastomaDecember 21, 2023 | finance.yahoo.comNorthwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For GlioblastomaNovember 22, 2023 | finance.yahoo.comNorthwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization ApplicationOctober 31, 2023 | morningstar.comNorthwest Biotherapeutics Inc NWBOOctober 14, 2023 | msn.comNorthwest Bio: Another Small Filing DelayOctober 13, 2023 | seekingalpha.comNW Bio dips on announcing delay in submission of marketing application for DCVaxOctober 13, 2023 | marketwatch.comNorthwest Biotherapeutics Shares Slide on Application DelayOctober 13, 2023 | finance.yahoo.comNorthwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization ApplicationSeptember 12, 2023 | finance.yahoo.comNorthwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory BoardAugust 17, 2023 | msn.comNorthwest Bio: Is There Ever Going To Be A Right Time?August 6, 2023 | usnews.comNorthwest Missouri State UniversityAugust 4, 2023 | health.usnews.comNorthwest HospitalJuly 15, 2023 | thestreet.comWhy Northwest Bio Is Shunned by Savvy Health Care InvestorsJune 19, 2023 | pnj.comThree rounds of severe weather expected over the next 24 hours for Northwest FloridaSee More Headlines Receive NWBO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Northwest Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/10/2024Today7/03/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:NWBO Previous SymbolNASDAQ:NWBO CUSIPN/A CIK1072379 Webwww.nwbio.com Phone(240) 497-9024Fax240-627-4121Employees25Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-62,600,000.00 Net Margins-5,258.91% Pretax Margin-5,258.91% Return on EquityN/A Return on Assets-241.52% Debt Debt-to-Equity RatioN/A Current Ratio0.08 Quick Ratio0.08 Sales & Book Value Annual Sales$1.93 million Price / Sales265.59 Cash FlowN/A Price / Cash FlowN/A Book Value($0.06) per share Price / Book-6.95Miscellaneous Outstanding Shares1,229,221,000Free Float1,122,279,000Market Cap$512.59 million OptionableNot Optionable Beta-0.57 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMs. Linda F. Powers J.D. (Age 68)Chairperson, CEO, President, CFO & Chief Accounting Officer Comp: $1.1MDr. Alton L. Boynton Ph.D. (Age 79)Founder, Chief Scientific Officer, Secretary & Director Comp: $450kDr. Marnix L. Bosch M.B.A. (Age 65)Ph.D., Chief Technical Officer Comp: $597.5kMr. Leslie J. Goldman (Age 79)Senior VP & General Counsel Comp: $825kMr. David InnesVice President of Investor RelationsKey CompetitorsJanux TherapeuticsNASDAQ:JANXProtagonist TherapeuticsNASDAQ:PTGXAmneal PharmaceuticalsNASDAQ:AMRXVera TherapeuticsNASDAQ:VERACatalyst PharmaceuticalsNASDAQ:CPRXView All Competitors NWBO Stock Analysis - Frequently Asked Questions How have NWBO shares performed in 2024? Northwest Biotherapeutics' stock was trading at $0.7010 at the start of the year. Since then, NWBO shares have decreased by 40.5% and is now trading at $0.4170. View the best growth stocks for 2024 here. Are investors shorting Northwest Biotherapeutics? Northwest Biotherapeutics saw a drop in short interest in June. As of June 15th, there was short interest totaling 47,353,700 shares, a drop of 14.0% from the May 31st total of 55,038,700 shares. Based on an average daily trading volume, of 2,945,900 shares, the short-interest ratio is currently 16.1 days. View Northwest Biotherapeutics' Short Interest. How were Northwest Biotherapeutics' earnings last quarter? Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) posted its quarterly earnings results on Friday, May, 10th. The biotechnology company reported ($0.02) earnings per share for the quarter. The biotechnology company earned $0.28 million during the quarter. What other stocks do shareholders of Northwest Biotherapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Northwest Biotherapeutics investors own include Clearside Biomedical (CLSD), Ocular Therapeutix (OCUL), Melinta Therapeutics (MLNT), (ZLTQ) (ZLTQ), Avid Bioservices (CDMO), Idera Pharmaceuticals (IDRA), Amarin (AMRN), Inovio Pharmaceuticals (INO) and MEI Pharma (MEIP). How do I buy shares of Northwest Biotherapeutics? Shares of NWBO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:NWBO) was last updated on 7/4/2024 by MarketBeat.com Staff From Our PartnersOperation Replace Biden is a GoLast night’s debate proved me right: Joe Biden will be replaced. I’ve been making this warning for months… ...The Freeport Society | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe End of Privacy for Americans… Get Out of Cash Now!Unlock the Secret to Outsmarting Inflation with "The Trump Loophole" That investment? Gold.Golden Crest | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredNvidia needs this one obscure firm In my new investigation, I detail why this is the single most important factor in the future of AI. I expla...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Northwest Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Northwest Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.